Cambridge Trust Company Has Increased Jpmorgan Chase & Co (JPM) Stake; Balchem (BCPC) Sellers Increased By 0.57% Their Shorts

January 14, 2018 - By Peter Kolinski

Balchem Corporation (NASDAQ:BCPC) had an increase of 0.57% in short interest. BCPC’s SI was 902,000 shares in January as released by FINRA. Its up 0.57% from 896,900 shares previously. With 76,000 avg volume, 12 days are for Balchem Corporation (NASDAQ:BCPC)’s short sellers to cover BCPC’s short positions. The SI to Balchem Corporation’s float is 2.87%. The stock decreased 0.87% or $0.71 during the last trading session, reaching $81.22. About 100,256 shares traded or 11.60% up from the average. Balchem Corporation (NASDAQ:BCPC) has risen 37.77% since January 14, 2017 and is uptrending. It has outperformed by 21.07% the S&P500.

Cambridge Trust Company increased Jpmorgan Chase & Co (JPM) stake by 3.35% reported in 2017Q3 SEC filing. Cambridge Trust Company acquired 4,150 shares as Jpmorgan Chase & Co (JPM)’s stock declined 6.04%. The Cambridge Trust Company holds 128,101 shares with $12.24 million value, up from 123,951 last quarter. Jpmorgan Chase & Co now has $390.88B valuation. The stock increased 1.65% or $1.83 during the last trading session, reaching $112.67. About 18.88M shares traded or 45.90% up from the average. JPMorgan Chase & Co. (NYSE:JPM) has risen 33.74% since January 14, 2017 and is uptrending. It has outperformed by 17.04% the S&P500.

Among 2 analysts covering Balchem (NASDAQ:BCPC), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Balchem had 3 analyst reports since March 8, 2016 according to SRatingsIntel. As per Friday, August 4, the company rating was maintained by Pivotal Research. The company was downgraded on Tuesday, March 8 by Sidoti. Pivotal Research downgraded the shares of BCPC in report on Friday, November 4 to “Sell” rating.

Investors sentiment increased to 1.58 in 2017 Q3. Its up 0.44, from 1.14 in 2017Q2. It is positive, as 16 investors sold Balchem Corporation shares while 39 reduced holdings. 18 funds opened positions while 69 raised stakes. 27.53 million shares or 3.97% more from 26.48 million shares in 2017Q2 were reported. Stillwater Advsr Ltd Company owns 26,152 shares. Strs Ohio has 79,400 shares for 0.03% of their portfolio. Alliancebernstein Limited Partnership owns 47,102 shares or 0% of their US portfolio. Minnesota-based Thrivent Fincl For Lutherans has invested 0.07% in Balchem Corporation (NASDAQ:BCPC). Ubs Asset Americas Incorporated has invested 0% in Balchem Corporation (NASDAQ:BCPC). Atlanta Cap L L C holds 0.12% of its portfolio in Balchem Corporation (NASDAQ:BCPC) for 261,627 shares. Sg Americas Secs Ltd Liability Com holds 0.01% in Balchem Corporation (NASDAQ:BCPC) or 15,535 shares. Comerica Bank reported 38,462 shares. Swiss Financial Bank reported 0% of its portfolio in Balchem Corporation (NASDAQ:BCPC). 455,312 were reported by Northern Corp. Eulav Asset Mgmt has invested 0.05% in Balchem Corporation (NASDAQ:BCPC). Salem Investment Counselors owns 136,134 shares. Credit Suisse Ag holds 37,975 shares or 0% of its portfolio. Riverhead Cap Management holds 0.01% of its portfolio in Balchem Corporation (NASDAQ:BCPC) for 1,434 shares. Ameriprise Fin Inc holds 214,859 shares or 0.01% of its portfolio.

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the United States and internationally. The company has market cap of $2.60 billion. The companyÂ’s Human Nutrition & Health segment offers creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, cereals, grain based snacks, and cereal based ingredients; microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. It has a 41.02 P/E ratio. The Company’s Animal Nutrition & Health segment provides microencapsulated products that enhance health and milk production in ruminant animals; chelation technology, which provides enhanced nutrient absorption for species; and choline chloride, an essential nutrient for monogastric animal health.

Among 32 analysts covering JPMorgan Chase & Co (NYSE:JPM), 17 have Buy rating, 2 Sell and 13 Hold. Therefore 53% are positive. JPMorgan Chase & Co had 99 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Monday, August 17 by Bruyette & Woods”. The firm has “Buy” rating by Buckingham Research given on Thursday, December 21. BMO Capital Markets maintained JPMorgan Chase & Co. (NYSE:JPM) on Wednesday, August 23 with “Hold” rating. The firm earned “Neutral” rating on Monday, January 25 by Nomura. The rating was upgraded by UBS on Friday, February 5 to “Buy”. On Tuesday, September 1 the stock rating was upgraded by Vetr to “Buy”. Barclays Capital maintained the shares of JPM in report on Friday, October 13 with “Overweight” rating. Sandler O’Neill downgraded JPMorgan Chase & Co. (NYSE:JPM) on Thursday, October 6 to “Hold” rating. The company was maintained on Friday, August 18 by Keefe Bruyette & Woods. Wells Fargo maintained JPMorgan Chase & Co. (NYSE:JPM) rating on Thursday, August 10. Wells Fargo has “Outperform” rating and $110 target.

Since August 21, 2017, it had 0 insider purchases, and 2 insider sales for $1.12 million activity. On Wednesday, October 25 Friedman Stacey sold $214,019 worth of JPMorgan Chase & Co. (NYSE:JPM) or 2,099 shares.

Investors sentiment decreased to 0.91 in 2017 Q3. Its down 0.28, from 1.19 in 2017Q2. It dived, as 65 investors sold JPM shares while 767 reduced holdings. 125 funds opened positions while 635 raised stakes. 2.50 billion shares or 7.05% less from 2.69 billion shares in 2017Q2 were reported. Rex Cap Limited owns 11,520 shares or 0.86% of their US portfolio. Brick Kyle Assocs holds 2.88% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 37,338 shares. Pacific Glob holds 69,568 shares or 1.5% of its portfolio. Ledyard Bancorp has invested 0.15% in JPMorgan Chase & Co. (NYSE:JPM). Tanaka Management Inc reported 0.42% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Miracle Mile Advsrs Ltd Liability Co invested in 0.07% or 4,569 shares. S&Co stated it has 25,021 shares or 0.31% of all its holdings. Roffman Miller Associates Inc Pa reported 279,988 shares. Buckhead Cap Mgmt Limited Liability Co invested in 112,395 shares or 2.31% of the stock. Marshwinds Advisory accumulated 4,119 shares or 0.18% of the stock. Main Street Rech Ltd Com has 158,038 shares. State Board Of Administration Of Florida Retirement Systems holds 1.34% or 5.16 million shares in its portfolio. Pennsylvania Trust owns 337,103 shares. Prudential Financial Incorporated has 10.21 million shares for 1.61% of their portfolio. Choate Invest holds 110,493 shares.

Cambridge Trust Company decreased Factset Research System Inc (NYSE:FDS) stake by 2,974 shares to 2,247 valued at $405,000 in 2017Q3. It also reduced Salesforce Com Inc (NYSE:CRM) stake by 7,895 shares and now owns 269,912 shares. Intl Business Machines Corp (NYSE:IBM) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>